SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-119322
Filing Date
2024-11-14
Accepted
2024-11-14 17:48:32
Documents
1
Group Members
5AM OPPORTUNITIES II (GP), LLC5AM OPPORTUNITIES II, L.P.5AM VENTURES VII, L.P.ANDREW J. SCHWABKUSH PARMAR

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427620d23_sc13ga.htm SC 13G/A 122819
  Complete submission text file 0001104659-24-119322.txt   124704
Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036 929-999-4055
Dianthus Therapeutics, Inc. /DE/ (Subject) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90538 | Film No.: 241464767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4 EMBARCADERO CENTER, SUITE 3110 SAN FRANCISCO CA 94111
Business Address 4 EMBARCADERO CENTER, SUITE 3110 SAN FRANCISCO CA 94111 (415) 993-8565
5AM Partners VII, LLC (Filed by) CIK: 0001873545 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A